Invention Grant
- Patent Title: Treating neurological disorders using selective antagonists of persistent sodium current
-
Application No.: US11326264Application Date: 2006-01-05
-
Publication No.: US07728034B2Publication Date: 2010-06-01
- Inventor: George R. Ehring , Joseph S. Adorante , Larry A. Wheeler , Thomas Malone , Scott M. Whitcup
- Applicant: George R. Ehring , Joseph S. Adorante , Larry A. Wheeler , Thomas Malone , Scott M. Whitcup
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agency: Allergan, Inc.
- Agent Dean G. Stathakis; Joel B. German
- Main IPC: A01N37/00
- IPC: A01N37/00 ; A61K31/21 ; A01N37/18 ; A61K31/16 ; A01N35/00 ; A61K31/12
Abstract:
The present invention provides methods of treating neurological disorders in a mammal by administering to the mammal an effective amount of a selective persistent sodium channel antagonist that has at least 20-fold selectivity for persistent sodium current relative to transient sodium current.
Public/Granted literature
- US20060106103A1 Treating neurological disorders using selective antagonists of persistent sodium current Public/Granted day:2006-05-18
Information query
